TrialCellular and molecular neurobiology2026

A Hypothesis-Generating Pharmacologic Profile for Sargramostim Treatment of Parkinson's Disease.

Susmita Sil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.